Cargando…

CXCR1/2 pathways in paclitaxel-induced neuropathic pain

Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a frequent and serious consequence of chemotherapy agents. Over the last years, significant progress has been achieved in elucidating the underlying pathogenesis of CIPN. The interference of taxanes with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laura, Brandolini, Elisabetta, Benedetti, Adelchi, Ruffini Pier, Roberto, Russo, Loredana, Cristiano, Andrea, Antonosante, Michele, d'Angelo, Vanessa, Castelli, Antonio, Giordano, Marcello, Allegretti, Annamaria, Cimini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410296/ https://www.ncbi.nlm.nih.gov/pubmed/28423567 http://dx.doi.org/10.18632/oncotarget.15533

Ejemplares similares

Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain
por: Brandolini, Laura, et al.
Publicado: (2019)

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
por: Brandolini, Laura, et al.
Publicado: (2015)

NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes
por: Brandolini, Laura, et al.
Publicado: (2020)

Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics
por: Antonosante, Andrea, et al.
Publicado: (2020)

DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
por: Brandolini, Laura, et al.
Publicado: (2019)

Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
por: Cuozzo, Mariarosaria, et al.
Publicado: (2021)

CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
por: Castelli, Vanessa, et al.
Publicado: (2021)

Looking for In Vitro Models for Retinal Diseases
por: Alfonsetti, Margherita, et al.
Publicado: (2021)

Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018)

The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
por: Antonosante, Andrea, et al.
Publicado: (2018)

The Role of Stiffness in Cell Reprogramming: A Potential Role for Biomaterials in Inducing Tissue Regeneration
por: d’Angelo, Michele, et al.
Publicado: (2019)

Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
por: Fidoamore, Alessia, et al.
Publicado: (2017)

Neuronal Cells Rearrangement During Aging and Neurodegenerative Disease: Metabolism, Oxidative Stress and Organelles Dynamic
por: Castelli, Vanessa, et al.
Publicado: (2019)

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
por: Fidoamore, Alessia, et al.
Publicado: (2016)

S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson’s Disease In Vitro Model
por: Catanesi, Mariano, et al.
Publicado: (2021)

L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson’s Disease
por: Catanesi, Mariano, et al.
Publicado: (2021)

Taurine and oxidative stress in retinal health and disease
por: Castelli, Vanessa, et al.
Publicado: (2021)

PPARs and Energy Metabolism Adaptation during Neurogenesis and Neuronal Maturation
por: D’Angelo, Michele, et al.
Publicado: (2018)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models
por: Antonosante, Andrea, et al.
Publicado: (2023)

Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
por: Brandolini, Laura, et al.
Publicado: (2022)

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)

Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019)

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019)

Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome
por: Brandolini, Laura, et al.
Publicado: (2022)

Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut
por: d’Angelo, Michele, et al.
Publicado: (2023)

Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice
por: Castelli, Vanessa, et al.
Publicado: (2023)

Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
por: Castelli, Vanessa, et al.
Publicado: (2020)

The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
por: Castelli, Vanessa, et al.
Publicado: (2021)

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
por: Catanesi, Mariano, et al.
Publicado: (2020)

Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
por: Catanesi, Mariano, et al.
Publicado: (2021)

Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
por: d’Angelo, Michele, et al.
Publicado: (2019)

The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020)

A State-of-the-Art of Functional Scaffolds for 3D Nervous Tissue Regeneration
por: Tupone, Maria Grazia, et al.
Publicado: (2021)

Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial
por: Piemonti, Lorenzo, et al.
Publicado: (2022)

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
por: d’Angelo, Michele, et al.
Publicado: (2020)

Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
por: Benedetti, Elisabetta, et al.
Publicado: (2015)

An Update on Graphene-Based Nanomaterials for Neural Growth and Central Nervous System Regeneration
por: Tupone, Maria Grazia, et al.
Publicado: (2021)

Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ
por: Caioni, Giulia, et al.
Publicado: (2021)

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
por: D’Egidio, Francesco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ntrduglsddrt5qdl41l9po2e0